Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review (Q64118653)

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Depression: the case for a monoamine deficiency.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The role of monoamine oxidase inhibitors in current psychiatric practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The role of the cannabinoid system in nicotine addiction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Antidepressant-like effects of ceftriaxone in male C57BL/6J mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroprotective potential of ceftriaxone in in vitro models of stroke.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Genetics of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Glutamate transmission in addiction

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Mitochondrial matters of the brain: mitochondrial dysfunction and oxidative status in epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Anti-allodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin-induced diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Long-term mortality of patients admitted to the hospital with alcohol withdrawal syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Animal models in the drug discovery pipeline for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the β-lactam antibiotic, ceftriaxone, in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone preconditioning confers neuroprotection in neonatal rats through glutamate transporter 1 upregulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The role of environmental exposures in neurodegeneration and neurodegenerative diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Alterations in neuronal survival and glial reactions after axotomy by ceftriaxone and minocycline in the mouse hypoglossal nucleus

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The effects of ceftriaxone on skill learning and motor functional outcome after ischemic cortical damage in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Effects of ceftriaxone on ischemia/reperfusion injury in rat brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The SLC1 high-affinity glutamate and neutral amino acid transporter family.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Monetary costs of dementia in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Mitochondrial dysfunction, oxidative stress, and major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Analgesic effect of a single preoperative dose of the antibiotic ceftriaxone in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Antihyperalgesic/antinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Excitatory amino acid transporters: roles in glutamatergic neurotransmission

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone pretreatment protects rats against cerebral ischemic injury by attenuating microglial activation-induced IL-1β expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone, a beta-lactam antibiotic, modulates apoptosis pathways and oxidative stress in a rat model of neuropathic pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone Protects Astrocytes from MPP(+) via Suppression of NF-κB/JNK/c-Jun Signaling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Amyloid-beta: a crucial factor in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Attenuation of morphine-induced dependence and tolerance by ceftriaxone and amitriptyline in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Glutamatergic transmission in drug reward: implications for drug addiction

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ameliorative potential of pioglitazone and ceftriaxone alone and in combination in rat model of neuropathic pain: Targeting PPARγ and GLT-1 pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Role of neuroinflammation in neurodegenerative diseases (Review)

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Beta Lactams Antibiotic Ceftriaxone Modulates Seizures, Oxidative Stress and Connexin 43 Expression in Hippocampus of Pentylenetetrazole Kindled Rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Toxin-Induced Experimental Models of Learning and Memory Impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Anthocyanins abrogate glutamate-induced AMPK activation, oxidative stress, neuroinflammation, and neurodegeneration in postnatal rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Protective Effect of Edaravone on Glutamate-Induced Neurotoxicity in Spiral Ganglion Neurons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The burden of neurological disease in the United States: A summary report and call to action

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson's disease in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Antiallodynic Activity of Ceftriaxone and Clavulanic Acid in Acute Administration is Associated with Serum TNF-α Modulation and Activation of Dopaminergic and Opioidergic Systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The Drug Repurposing Hub: a next-generation drug library and information resource

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Antioxidants reduce neurodegeneration and accumulation of pathologic Tau proteins in the auditory system after blast exposure

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Filling the gap in CNS drug development: evaluation of the role of drug repurposing

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Quantifying absolute glutamate concentrations in nucleus accumbens of prescription opioid addicts by using 1H MRS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Disease modification and Neuroprotection in neurodegenerative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Towards earlier diagnosis and treatment of disorders of the brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Effects of the excitatory amino acid transporter subtype 2 (EAAT-2) inducer ceftriaxone on different pain modalities in rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/30971875

1 reference

12 December 2020

Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroprogression: the hidden mechanism of depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

Neuroinflammation in the central nervous system: Symphony of glial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020

The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure

1 reference

https://pubmed.ncbi.nlm.nih.gov/30971875

12 December 2020